Skip to content

Clinical trials

Active, not recruiting Neoplasm Metastasis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Active, not recruiting Country / region: Australia Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20163
20182
20196
20201
202110
202212
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Eli Lilly and Company5
AbbVie2
Genentech, Inc.2
Novartis Pharmaceuticals2
ARCAGY/ GINECO GROUP1
Alterome Therapeutics, Inc.1
Ambrx, Inc.1
Ascendis Pharma Oncology Division A/S1
BioAtla, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis41
Carcinoma, Non-Small-Cell Lung12
Breast Neoplasms8
Neoplasms8
Colorectal Neoplasms6
Prostatic Neoplasms6
Endometrial Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Carcinoma3
Melanoma3

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.